These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease. Wu X; Kosaraju J; Zhou W; Tam KY Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769 [TBL] [Abstract][Full Text] [Related]
7. Toward an early diagnosis and treatment of Alzheimer's disease. Nordberg A Int Psychogeriatr; 2003 Sep; 15(3):223-37. PubMed ID: 14756159 [TBL] [Abstract][Full Text] [Related]
8. Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease? Dunys J; Valverde A; Checler F J Biol Chem; 2018 Oct; 293(40):15419-15428. PubMed ID: 30143530 [TBL] [Abstract][Full Text] [Related]
9. "Amyloid-beta accumulation cycle" as a prevention and/or therapy target for Alzheimer's disease. Rao CV; Asch AS; Carr DJJ; Yamada HY Aging Cell; 2020 Mar; 19(3):e13109. PubMed ID: 31981470 [TBL] [Abstract][Full Text] [Related]
10. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model. Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145 [TBL] [Abstract][Full Text] [Related]
11. The combination of aricept with a traditional Chinese medicine formula, smart soup, may be a novel way to treat Alzheimer's disease. Wang Y; Wang Y; Sui Y; Yu H; Shen X; Chen S; Pei G; Zhao J; Ding J J Alzheimers Dis; 2015; 45(4):1185-95. PubMed ID: 25690664 [TBL] [Abstract][Full Text] [Related]
12. Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer's Disease. Kim J Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805772 [TBL] [Abstract][Full Text] [Related]
13. Metal Ions in Alzheimer's Disease: A Key Role or Not? Liu Y; Nguyen M; Robert A; Meunier B Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278 [TBL] [Abstract][Full Text] [Related]
14. AMPK: Potential Therapeutic Target for Alzheimer's Disease. Yang L; Jiang Y; Shi L; Zhong D; Li Y; Li J; Jin R Curr Protein Pept Sci; 2020; 21(1):66-77. PubMed ID: 31424367 [TBL] [Abstract][Full Text] [Related]
15. Connective tissue growth factor (CTGF) expression in the brain is a downstream effector of insulin resistance- associated promotion of Alzheimer's disease beta-amyloid neuropathology. Zhao Z; Ho L; Wang J; Qin W; Festa ED; Mobbs C; Hof P; Rocher A; Masur S; Haroutunian V; Pasinetti GM FASEB J; 2005 Dec; 19(14):2081-2. PubMed ID: 16186174 [TBL] [Abstract][Full Text] [Related]
16. Hyperspectral imaging signatures detect amyloidopathy in Alzheimer's mouse retina well before onset of cognitive decline. More SS; Vince R ACS Chem Neurosci; 2015 Feb; 6(2):306-15. PubMed ID: 25354367 [TBL] [Abstract][Full Text] [Related]
17. A small molecule transcription factor EB activator ameliorates beta-amyloid precursor protein and Tau pathology in Alzheimer's disease models. Song JX; Malampati S; Zeng Y; Durairajan SSK; Yang CB; Tong BC; Iyaswamy A; Shang WB; Sreenivasmurthy SG; Zhu Z; Cheung KH; Lu JH; Tang C; Xu N; Li M Aging Cell; 2020 Feb; 19(2):e13069. PubMed ID: 31858697 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease. Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165 [TBL] [Abstract][Full Text] [Related]
19. Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease. Blain JF; Bursavich MG; Freeman EA; Hrdlicka LA; Hodgdon HE; Chen T; Costa DE; Harrison BA; Kapadnis S; Murphy DA; Nolan S; Tu Z; Tang C; Burnett DA; Patzke H; Koenig G Alzheimers Res Ther; 2016 Aug; 8(1):34. PubMed ID: 27572246 [TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacology of novel anti-Alzheimer disease modifying medications. Caraci F; Bosco P; Leggio GM; Malaguarnera M; Drago F; Bucolo C; Salomone S Curr Top Med Chem; 2013; 13(15):1853-63. PubMed ID: 23931438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]